Pulmonary Function after Proton Therapy for Hodgkin Lymphoma

PURPOSE: Acute and late toxicity from chemotherapy, targeted therapy, and radiation therapy can cause significant morbidity among survivors of Hodgkin lymphoma (HL), including pulmonary dysfunction. Improved dosimetry may influence pulmonary function tests (PFTs), an objective and clinically signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: O'steen, Lillie, Bellardini, Jason, Cury, James, Jones, Lisa, Seeram, Vandana K., Mendenhall, Nancy P., Hoppe, Bradford S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Particle Therapy Co-operative Group 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874186/
https://www.ncbi.nlm.nih.gov/pubmed/31788502
http://dx.doi.org/10.14338/IJPT-18-00040.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874186/
https://www.ncbi.nlm.nih.gov/pubmed/31788502
http://dx.doi.org/10.14338/IJPT-18-00040.1

Ejemplares similares